[Clinical significance of various metabolic disorders in patients with chronic pancreatitis].

Abstract

The degree of hyperlipidemia, hyperthyrosinemia, hyperserotoninemia and enhanced release of bradykinin from kininogen in patients with chronic recurrent pancreatitis was found to be decreased upon the attainment of a clinical remission. In patients with more considerable and more stable metabolic disorders, the incidence of exacerbations and the rate of progression of pancreatic, enzyme-secretory deficiency appeared, according to the data of a 8-year follow up, greater than in those with lesser degree and resistance of metabolic shifts.

• Authors: L I Geller, A P Kazimirchuk, A G Amatniak
• Journal: Terapevticheskii arkhiv (Ter Arkh) Vol. 56 Issue 11 Pg. 70-2 ( 1984) ISSN: 0040-3660 [Print] Russia (Federation)
• Vernacular Title: Klinicheskoe znachenie nekotorykh metabolicheskikh narusheniĭ u bol'nykh khronicheskim pankreatitom.
• PMID: 6523393 (Publication Type: English Abstract, Journal Article)

Chemical References

• Fatty Acids, Nonesterified
• Triglycerides
• Serotonin
• Tyrosine

Topics

• Chronic Disease
• Fatty Acids, Nonesterified (blood)
• Humans
• Hyperlipidemias (etiology)
• Pancreatitis (metabolism)
• Recurrence
• Serotonin (blood)
• Triglycerides (blood)
• Tyrosine (blood)